摘要
背景:脂质是细胞的重要组成部分,参与代谢和内分泌调节以及生殖功能。进行脂质调节的主要器官是肝脏和脂肪组织。此外,当每种组织特异性作用无法发挥时,可能导致多种与 PCOS 密切相关的内分泌代谢紊乱,如非酒精性脂肪肝 (NAFLD) 和肥胖症。 目的:这项工作旨在讨论脂质改变对代谢和生殖健康的影响。因此,本综述侧重于对 PCOS 中受影响的分子途径进行综合研究以开发靶向疗法的重要性。 结果:脂质在 PCOS 发病机制中起主要作用。在这方面,脂质调节、合成和/或体内平衡的失败会导致代谢和生殖异常,例如在 PCOS 中看到的异常。这种病理改变了几种脂质途径和调节剂,导致生殖功能恶化的功能障碍。因此,有几种治疗方法可以控制血脂异常。非药物治疗被认为是一线治疗,而药物治疗则是二线选择。 结论:改善血脂状况的最佳治疗方法是生活方式干预,低热量饮食和运动相结合。关于药物治疗,贝特类药物和他汀类药物的组合将是最推荐的药物。尽管如此,在 PCOS 女性中,二甲双胍或 TZD 治疗不仅可以调节脂质代谢,还可以改善排卵。此外,生活方式干预的二甲双胍对 PCOS 患者的代谢和生殖特征有积极影响。
关键词: 脂质代谢紊乱、脂质调节剂、生殖功能、多囊卵巢综合征、药物治疗、他汀类药物和贝特类药物、二甲双胍。
Current Medicinal Chemistry
Title:Lipid Metabolism and Relevant Disorders to Female Reproductive Health
Volume: 28 Issue: 27
关键词: 脂质代谢紊乱、脂质调节剂、生殖功能、多囊卵巢综合征、药物治疗、他汀类药物和贝特类药物、二甲双胍。
摘要:
Background: Lipids are essential components of cells that participate in metabolic and endocrine regulation and reproductive functions. The main organs where lipid regulation takes place are the liver and adipose tissue. Besides, when each tissue- specific action cannot be exerted, it could lead to several endocrine-metabolic disorders closely related to PCOS, such as non-alcoholic fatty liver disease (NAFLD) and obesity.
Objective: This work aims to discuss the impact of lipid alterations on metabolic and reproductive health. Therefore, this review focus on the importance of carrying out an integrated study of the molecular pathways affected in PCOS for developing target therapies.
Results: Lipids play a major role in PCOS pathogenesis. In this regard, failures in lipid regulation, synthesis, and/or homeostasis contribute to metabolic and reproductive abnormalities, such as those seen in PCOS. Several lipid pathways and regulators are altered in this pathology, leading to dysfunctions that worsen reproductive functions. Therefore, there are several treatments to manage dyslipidemias. Non-pharmacological therapies are considered a first-line treatment being the pharmacological treatments a second-line option.
Conclusion: The best treatment to improve the lipid profile is lifestyle intervention, a combination of hypocaloric diet and exercise. Regarding pharmacological therapies, a combination of fibrate and statins would be the most recommended drugs. Still, in PCOS women, treatment with metformin or TZDs not only modulates the lipid metabolism, but also improves ovulation. In addition, metformin with lifestyle interventions has positive effects on the metabolic and reproductive features of PCOS patients.
Export Options
About this article
Cite this article as:
Lipid Metabolism and Relevant Disorders to Female Reproductive Health, Current Medicinal Chemistry 2021; 28 (27) . https://dx.doi.org/10.2174/0929867328666210106142912
DOI https://dx.doi.org/10.2174/0929867328666210106142912 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV Compartmentalization: A Review on a Clinically Important Phenomenon
Current HIV Research Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Mitochondria: A Promising Target for Anticancer Alkaloids
Current Topics in Medicinal Chemistry Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
Current Chemical Biology Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Hereditary Breast Cancer in Sub-Saharan Africa
Current Women`s Health Reviews Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery Non-Steroidal Targets in the Diagnosis and Treatment of Endometriosis
Current Medicinal Chemistry Small Molecule Inhibitors of Multidrug Resistance Gene (MDR1) Expression: Preclinical Evaluation and Mechanisms of Action
Current Cancer Drug Targets Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Current Vascular Pharmacology Epigenetic Modification Restores Functional PR Expression in Endometrial Cancer Cells
Current Pharmaceutical Design Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
Current Molecular Medicine Possible Role of PTEN Expression in Discriminating Benign Endometrial Hyperplasia from Atypical Hyperplasia/Endometrial Intraepithelial Neoplasia in a Series of Egyptian Patients
Current Women`s Health Reviews The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Current Medical Imaging The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets Management of the Menopausal Disturbances and Oxidative Stress
Current Pharmaceutical Design Three-Dimensional Ultrasound in Gynecology: Current Status and Future Perspectives
Current Women`s Health Reviews Acylation Stimulating Protein and Triacylglycerol Synthesis: Potential Drug Targets?
Current Pharmaceutical Design Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine